Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: Results of a randomized controlled trial (STARCH)

Nephrology Dialysis Transplantation

Volumn 30, Issue 11, 2015, Pages 1905-1911

  De Moraes, Thyago Proença ^a   Cruz Andreoli, Maria Cláudia ^b   Canziani, Maria Eugênia ^b   Da Silva, Dirceu Reis ^c   Teixeira Caramori, Jacqueline Costa ^d   Ponce, Daniela ^d   Cassi, Hélio Vida ^e   De Andrade Bastos, Kleyton ^f   Alves Rio, Danyelle Romana ^g   Pinto, Sergio Wyton ^g   Ferreira Filho, Sebastião Rodrigues ^h   De Campos, Ludimila Guedim ^a   Olandoski, Marcia ^a   Divino Filho, José Carolino ⁱ   Pecoits Filho, Roberto ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Hospital Santa Casa de Misericórdia de Curitiba   (Brazil)

^f FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^g Division of Nephrology Hospital Sao Joao de Deus   (Brazil)

^h FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Icodextrin; Insulin resistance; Non diabetic; Peritoneal dialysis

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; ICODEXTRIN; INSULIN; DIALYSIS FLUID; GLUCAN;

ADULT; ARTICLE; AUTOMATED PERITONEAL DIALYSIS; AUTOMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC PARAMETERS; MIDDLE AGED; MULTICENTER STUDY; NON DIABETIC PATIENT; OPEN STUDY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT; PATIENT SAFETY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRAFILTRATION; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; PHASE 4 CLINICAL TRIAL; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RISK FACTORS;

EID: 84948438759     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv247     Document Type: Article

References (25)

1. Foley RN, Parfrey PS. Risk factors for cardiac morbidity and mortality in dialysis patients. Curr Opin Nephrol Hypertens 1994; 3: 608-614
2. Plantinga LC, Fink NE, LevinNW et al. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis 2007; 49: 831-840
3. Kobayashi S,Maejima S, Ikeda T et al. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2000; 15: 65-70
4. de Moraes TP, Pecoits-Filho R. Metabolic impact of peritoneal dialysis. Contrib Nephrol 2009; 163: 117-123
5. Fortes PC, de Moraes TP, Mendes JG et al. Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int 2009; 29(Suppl 2): S145-S148
6. Qi H, Xu C, YanHet al. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit Dial Int 2011; 31: 179-188
7. Paniagua R, Ventura MD, Avila-Diaz M et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int 2009; 29: 422-432
8. Li PK, Culleton BF, Ariza A et al. Randomized, controlled trial of glucosesparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 2013; 24: 1889-1900
9. Shinohara K, Shoji T, Emoto M et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900
10. Canbakan M, Sahin GM. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients. Ren Fail 2007; 29: 289-293
11. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63
12. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
13. Szeto CC, Chow KM, Kwan BC et al. New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis. 2007; 49: 524-532
14. Duong U, Mehrotra R, Molnar MZ et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 2011; 6: 1041-1048
15. Yoo DE, Park JT, Oh HJ et al. Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study. PloS One. 2012; 7: e30072
16. Menon V, Greene T, Pereira AA et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005; 16: 3411-3417
17. Babazono T, Nakamoto H, Kasai K et al. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol 2007; 27: 409-415
18. Sanchez-Villanueva R, Estrada P, del Peso G et al. Repeated analysis of estimated insulin resistance using the HOMAIRindex in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality. Nefrologia 2013; 33: 85-92
19. Li Y, Zhang L, Gu Y et al. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis. Perit Dial Int 2013; 33: 411-418
20. Johnson DW, Arndt M, O'Shea A et al. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2: 2
21. Amici G, Orrasch M, Da Rin G et al. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001; 17: 80-83
22. Reis da Silva D, Figueiredo AE, Antonelo IC et al. Solutes transport characteristics in peritoneal dialysis: variation in glucose and insulin serum levels. Ren Fail 2008; 30: 1-5
23. Twardowski Z, Nolph KO, Khann R et al. Peritoneal equilibration test. Perit Dial Int 1987; 7: 138-148
24. Cho KH, Do JY, Park JWet al. Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients. Nephrol Dial Transplant 2010; 25: 593-599
25. He Q, ZhangW, Chen J. A meta-analysis of icodextrin versus glucose containing peritoneal dialysis in metabolic management of peritoneal dialysis patients. Ren Fail 2011; 33: 943-948